Epithelial Cell Reprogramming on Laminin for Efficient iPS Induction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing induced pluripotent stem cells (iPS cells) are limited in their efficiency and often require invasive sample collection, particularly when using somatic cells like fibroblasts or keratinocytes, and there is a need for a more efficient and non-invasive method using epithelial cells.

Innovation Solution

A method involving reprogramming epithelial cells, derived from the outer root sheath of hair follicles, using a laminin-coated culture surface and incorporating specific genes (Oct3/4, Klf4, Sox2, and optionally c-Myc) while inhibiting p53 function, and culturing in serum-free and xeno-free conditions to enhance iPS cell production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional methods using fibroblasts or keratinocytes are used for iPS cell production, then iPS cells can be established, but the sample collection is invasive and establishment efficiency is limited

Engineering Contradiction:
ImproveiPS cell establishment efficiencyVSAvoidinvasiveness of sample collection
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The invention changes the cell type parameter from conventional fibroblasts or keratinocytes to epithelial cells obtained through non-invasive methods (urine, saliva, hair follicles). This parameter change in cell source enables both non-invasive sample collection and efficient iPS cell establishment, resolving the contradiction between invasiveness and establishment efficiency

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention utilizes easily obtainable, non-invasive biological samples (urine, saliva, hair) that can be collected without medical intervention. These samples serve as disposable sources of epithelial cells, eliminating the need for invasive procedures while providing sufficient material for iPS cell generation

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Productivity

If serum-containing culture medium is used for epithelial cell culture, then cell proliferation is supported, but the method is not xeno-free and may affect iPS cell quality

Engineering Contradiction:
Improvecell proliferation efficiencyVSAvoidxeno-free culture compatibility
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The invention changes the culture medium composition parameter by replacing serum-containing medium with serum-free and xeno-free medium. This parameter change maintains cell proliferation efficiency while achieving xeno-free conditions, enabling the culture of epithelial cells and subsequent iPS cell generation without animal-derived components

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The serum-free and xeno-free culture medium is designed to provide all necessary nutrients and growth factors without serum supplementation. The medium components work synergistically to support epithelial cell and iPS cell proliferation autonomously, eliminating dependency on animal serum

Inventive Principle:
Principle #25Self-service

3Productivity

If p53 function is not inhibited during reprogramming, then genomic stability is maintained, but reprogramming efficiency is reduced

Engineering Contradiction:
Improvereprogramming efficiencyVSAvoidgenomic stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention applies partial inhibition of p53 function rather than complete suppression. By using moderate p53 inhibition (through chemical inhibitors or dominant-negative mutants), the method achieves sufficient reprogramming efficiency while maintaining adequate genomic stability, balancing both requirements through controlled partial action

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS20250368965A1Method for producing induced pluripotent stem cells using epithelial cells
Publication Date: 2025.12.04 POLA CHEMICAL INDUSTRIES INC
  • US20250368965A1 patent drawing
  • US20250368965A1 patent drawing
  • US20250368965A1 patent drawing

AI summary

A first problem of the present invention is to provide a novel technique capable of producing iPS cells using epithelial cells such as keratinocytes. The present invention for solving the problem is a method for producing induced pluripotent stem cells using epithelial cells, the method including: a reprogramming step including introducing a reprogramming gene for reprogramming a nucleus, or a translation product thereof, into the epithelial cells; and an adherent culture step of adhering and culturing cells that have undergone the reprogramming step on a culture surface coated with a laminin or a fragment thereof.